Document Detail


Diagnosis delay in patients with ankylosing spondylitis: possible reasons and proposals for new diagnostic criteria.
MedLine Citation:
PMID:  17899306     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Ankylosing spondylitis (AS) is a chronic, progressive, and disabling disease. Among the rheumatological diseases, the longest diagnosis delay is still found for AS. The aim of this cross-sectional study is to evaluate the diagnosis delay and possible reasons in AS. A secondary aim is to assess the relation between diagnosis delay and some clinical and laboratory features. One hundred eleven AS patients, (103 male, 8 female) were recruited. A face-to-face interview was applied to take medical history, and a questionnaire that contains some clinical aspects of disease was used. Diagnosis delay was described as the gap between first spondiloarthropathic symptom and correct diagnosis of AS. The average of diagnosis delay was 6.05 +/- 5.08 years. The average age of patients at disease onset was 23.18 +/- 9.59, the average disease duration was 10.44 +/- 8.11, and the average age at diagnosis was 27.88 +/- 11.63. The average diagnosis delay was 5. 3 +/- 3.5 in HLA B 27(+) AS patients, whereas it was 9.2 +/- 7.7 in HLA B 27(-) AS patients (p = 0.037). Diagnosis delay in patients with inflammatory back pain (+) (IBP) at disease onset was lower than IBP (-) patients (3.28 +/- 3.32, 8.57 +/- 8.54; respectively) (p = 0.001). The patients having positive family history had lower diagnosis delay than those with negative family history (4.60 +/- 4.44, 10.00 +/- 2.30; respectively) (p = 0.003). The diagnosis delay is a challenge and an important problem for patients with AS and physicians. HLA B27 and family history should be considered while making new criteria. Inflammatory back pain should be emphasized as the main screening criterion for primary care physicians. These clinical and laboratory features had positive effect on the average diagnosis delay in AS patients. Describing new diagnostic criteria, which is more useful to diagnosis of AS, is necessary.
Authors:
Umit Dincer; Engin Cakar; M Zeki Kiralp; Hasan Dursun
Related Documents :
8881806 - An impaired phagocytic function is associated with leucocyte activation in the early st...
12612516 - Use of methylene blue to identify the minor papilla or its orifice in patients with pan...
6300626 - The association of aniridia and wilms' tumor: methods of surveillance and diagnosis.
22078666 - Lipoprotein(a) and inflammation in patients with atrial fibrillation after electrical c...
16319456 - Trends in incidence of colorectal cancer in jewish and arab populations in central israel.
12694346 - Study of heart and renal protection (sharp).
Publication Detail:
Type:  Journal Article     Date:  2007-09-26
Journal Detail:
Title:  Clinical rheumatology     Volume:  27     ISSN:  0770-3198     ISO Abbreviation:  Clin. Rheumatol.     Publication Date:  2008 Apr 
Date Detail:
Created Date:  2008-03-12     Completed Date:  2008-06-17     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8211469     Medline TA:  Clin Rheumatol     Country:  Belgium    
Other Details:
Languages:  eng     Pagination:  457-62     Citation Subset:  IM    
Affiliation:
Department of Physical Medicine and Rehabilitation, Gulhane Military Medical Academy, Haydarpasa Training Hospital, Istanbul, Turkey. drumitdincer@yahoo.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Back Pain / diagnosis,  etiology
Cross-Sectional Studies
Disease Progression
Early Diagnosis*
Female
HLA-B27 Antigen / blood
Humans
Male
Medical History Taking
Middle Aged
Spondylitis, Ankylosing / complications,  diagnosis*,  immunology
Time Factors
Chemical
Reg. No./Substance:
0/HLA-B27 Antigen

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  IL1RN*2 allele of IL-1receptor antagonist VNTR polymorphism is associated with susceptibility to ank...
Next Document:  The clinical significance of serum N-terminal pro-brain natriuretic peptide in systemic sclerosis pa...